BEAT Therapeutics is a pharmaceutical startup driven by an unwavering commitment to transforming cancer care.
Our mission is to develop more effective therapeutic options for patients facing hard-to-treat cancers.
We present an innovative, FIRST-IN-CLASS targeted therapy against aggressive cancers.
Our first drug candidate exhibits unprecedented efficacy, being the first to target a key driver pathway in cancer cells, the BRCA1/BARD1.
